On the 10th of August, Wednesday, the Union Health Ministry approved another vaccine as the booster dose against the Wuhan virus, also known as the Novel Coronavirus (COVID-19.)
According to sources, the Biological E manufactured Corbevax has been approved as the precautionary or booster dose for the eligible adult population, (above 18 years) in India. Furthermore, this is the first time that the Indian Health Ministry approved a different booster dose for those who got double vaccination of different vaccines, either COVAXIN or Covishield.
It is to be noted, the newly approved Corbevax would be given to the people who received two doses of any of the approved, the Serum Institute of India’s Covishield or the Bharat Biotech Private Limited manufactured COVAXIN. Moreover, the ideal duration gap between the two doses and the booster dose would be six months or 26 weeks.
Getting into the details, the approval for Corbevax was based on the recommendations of the National Technical Advisory Group on Immunisation (NTAGI.) Furthermore, a source close to the development, wishing anonymity said, “Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those aged above 18 years enabling use of Corbevax as a heterologous COVID-19 vaccine for precaution dose administration in this age group.”
With this, India now has three vaccines Corbevax, Covishield, and COVAXIN as the booster dose, which has been approved by the Drugs Controllers General of India and the Union Health Ministry.
Stay tuned for further updates.
Mango News Link
Telegram: https://t.me/mangonewsofficial
Google Play Store: https://bit.ly/2R4cbgN
Apple / iOS Store: https://apple.co/2xEYFJ
